respiratory disorders

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Respiratory Disorders Trial in Canada, Germany, United Kingdom (NTHi Mcat investigational vaccine (GSK3277511A), Placebo)

Completed
  • Respiratory Disorders
  • NTHi Mcat investigational vaccine (GSK3277511A)
  • Placebo
  • Truro, Nova Scotia, Canada
  • +7 more
Aug 4, 2021

Respiratory Disorders Trial in Gent, Leuven, Wilrijk (Blood sampling, GSK biologicals investigational NTHi Mcat vaccine

Completed
  • Respiratory Disorders
  • Blood sampling
  • +3 more
  • Gent, Belgium
  • +2 more
Mar 12, 2021

Respiratory Disorders Trial in Worldwide (NTHi Mcat investigational vaccine (GSK3277511A), Placebo)

Completed
  • Respiratory Disorders
  • NTHi Mcat investigational vaccine (GSK3277511A)
  • Placebo
  • Mesa, Arizona
  • +66 more
Jan 8, 2021

Respiratory Disorders Trial in Cincinnati (Hyperpolarized 129 Xenon)

Recruiting
  • Respiratory Disorders
  • Hyperpolarized 129 Xenon
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 17, 2020

Respiratory Disorders Trial in Cincinnati (Hyperpolarized 129 Xenon, MRI)

Recruiting
  • Respiratory Disorders
  • Hyperpolarized 129 Xenon
  • MRI
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 17, 2020

Respiratory Disorders Trial in Belfast, Harrow (GSK1995057, bronchoalveolar lavage, LPS)

Completed
  • Respiratory Disorders
  • Belfast, United Kingdom
  • +1 more
Jun 25, 2019

Respiratory Disorders Trial in Southampton (Blood sample, Sputum sample, Nasopharyngeal swab)

Completed
  • Respiratory Disorders
  • Blood sample
  • +6 more
  • Southampton, Hampshire, United Kingdom
    GSK Investigational Site
Feb 8, 2019

Proprioceptive Postural Control and Diaphragm Paresis

Withdrawn
  • Proprioceptive Postural Control
  • +2 more
    • Leuven, Vlaams-Brabant, Belgium
      Katholieke Universiteit Leuven
    Feb 7, 2019

    Respiratory Disorders Trial in Gent, Leuven, Wilrijk (Formulation 1 (plain): NTHi/Mcat vaccine GSK3277513A, Formulation 2

    Completed
    • Respiratory Disorders
    • Formulation 1 (plain): NTHi/Mcat vaccine GSK3277513A
    • +3 more
    • Gent, Belgium
    • +2 more
    Aug 3, 2018

    Respiratory Disorders Trial in Sweden, United Kingdom (NTHi-10-AS01E, NaCl Placebo)

    Completed
    • Respiratory Disorders
    • NTHi-10-AS01E
    • NaCl Placebo
    • Eskilstuna, Sweden
    • +13 more
    Jun 14, 2018

    Respiratory Disorders Trial in Harrow (GSK1995057 single dose, Placebo)

    Completed
    • Respiratory Disorders
    • GSK1995057 single dose
    • Placebo
    • Harrow, Middlesex, United Kingdom
      GSK Investigational Site
    Jun 9, 2017

    Respiratory Disorders Trial in Brussels, Gent, Liège (Blood collection, Swab collection, Sputum collection)

    Completed
    • Respiratory Disorders
    • Blood collection
    • +2 more
    • Brussels, Belgium
    • +2 more
    Apr 12, 2017

    Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

    Completed
    • Respiratory Disorders
    • Salmeterol and Fluticasone
    • (no location specified)
    May 15, 2017

    Respiratory Disorders Trial in Antwerpen, Gent, Wilrijk (NTHI vaccine GSK2838500A (formulation 1), NTHI vaccine GSK2838501A

    Completed
    • Respiratory Disorders
    • NTHI vaccine GSK2838500A (formulation 1)
    • +8 more
    • Antwerpen, Belgium
    • +2 more
    May 12, 2017

    Respiratory Disorders Trial in Hyderabad (Reference Montelukast, Test 1 Montelukast, Test 2 Montelukast)

    Completed
    • Respiratory Disorders
    • Reference Montelukast
    • +2 more
    • Hyderabad, India
      GSK Investigational Site
    May 12, 2017

    Respiratory Disorders Trial in Adelaide (GSK Biologicals' Non-Typeable H. influenzae (GSK2838500A), GSK Biologicals'

    Completed
    • Respiratory Disorders
    • GSK Biologicals' Non-Typeable H. influenzae (GSK2838500A)
    • +2 more
    • Adelaide, South Australia, Australia
      GSK Investigational Site
    May 12, 2017

    Respiratory Disorders Trial in Harrow (Single IV dose of GSK2862277, Matching single dose IV infusion, Single IH dose of

    Completed
    • Respiratory Disorders
    • Single IV dose of GSK2862277
    • +7 more
    • Harrow, Middlesex, United Kingdom
      GSK Investigational Site
    May 12, 2017

    Respiratory Disorders, Asthma and Rhinitis Trial in Telangana (Test Montelukast, Reference Montelukast)

    Completed
    • Respiratory Disorders
    • Asthma and Rhinitis
    • Test Montelukast
    • Reference Montelukast
    • Telangana, India
      GSK Investigational Site
    May 5, 2017

    COPD, COPD Exacerbation, Lung Diseases Trial in Worldwide (Roflumilast, Placebo)

    Completed
    • COPD
    • +6 more
    • Anniston, Alabama
    • +337 more
    Mar 16, 2017

    Respiratory Disorders, Intensive Care, Neonatal Trial in Denmark (Elective caesarean section)

    Completed
    • Respiratory Disorders
    • Intensive Care, Neonatal
    • Elective caesarean section
    • Aalborg, Denmark
    • +6 more
    Jun 3, 2014

    Inspiratory Muscle Training, Low Back Pain, Respiratory Disorders Trial in Leuven (Inspiratory muscle training, Sham inspiratory

    Completed
    • Inspiratory Muscle Training
    • +2 more
    • Inspiratory muscle training
    • Sham inspiratory muscle training
    • Leuven, Belgium
      Katholieke Universiteit Leuven
    Dec 10, 2013

    ADOAIR (Fluticasone/Salmeterol)

    Completed
    • Respiratory Disorders
    • Salmeterol and Fluticasone
    • (no location specified)
    Aug 20, 2013

    Electrocardiographic Autonomic Function Measures in Mechanically

    Withdrawn
    • Disorders of the Autonomic Nervous System
    • +2 more
      • San Francisco, California
        University of California, San Francisco Medical Center
      Mar 26, 2012

      Fibrosis, Lung Disease, Respiratory Disorders Trial in Worldwide (EPI-hNE4, Placebo)

      Completed
      • Fibrosis
      • +6 more
      • Angers, France
      • +13 more
      Jun 23, 2008